United Kingdom — National Health Service & Bleichmar Fonti & Auld LLP

United Kingdom — National Health Service: The NHS-Galleri trial, conducted in partnership with the UK's United Kingdom — National Health Service, failed to meet its primary endpoint. This outcome may affect the NHS's evaluation of the Galleri test for national screening programs, though the NHS itself is not a defendant in the lawsuits.

Bleichmar Fonti & Auld LLP: BFA filed a class action lawsuit against Illumina — Holy Grail and certain executives, alleging securities fraud related to the NHS-Galleri trial. The firm is actively soliciting investors to join the case.

United Kingdom — National Health Service: The NHS conducted the Galleri trial in the UK; the trial's failure may affect future collaboration with Illumina — Holy Grail.

Bleichmar Fonti & Auld LLP: Bleichmar Fonti & Auld LLP is one of the law firms that filed the class action lawsuit against Illumina — Holy Grail, representing investors.